Nucala 100 mg/mL, Injektionslösung im Fertigpen

7680673500026 CH-67350 Injektionslösung im Fertigpen

Associated product:

NUCALA sol inj 100 mg/ml stylo prérempli 3 pce
Nucala 100 mg/mL, Injektionslösung im Fertigpen
Nucala 100 mg/mL, Injektionslösung im Fertigpen
Nucala 100 mg/mL, Injektionslösung im Fertigpen
1 / 3
google

Article details

Package size
3 x 1
Selling units
3
Measure
Stück
Galenic form
Injektionslösung im Fertigpen
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
26/07/2025
Patient information leaflet
Français
26/07/2025
Patient information leaflet
Italien
26/07/2025
Summary of Product Characteristics
Allemand
26/07/2025
Summary of Product Characteristics
Français
26/07/2025
Summary of Product Characteristics
Italien
26/07/2025

Detailed composition

Substance Quantity Type Category
(N/A)
100.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
natrium
0.72 MG Substance HBESI

Authorization holder

GlaxoSmithKline AG

6340 Baar

Authorization information

Swissmedic authorization number
67350
Drug name
Nucala, Injektionslösung im Fertigpen
Galenic form
INLFP
ATC Code
R03DX09
Authorization status
Z
Dispensing category
B
First authorization
13/02/2020
Authorization expiration date
31/12/9999
IT Number
03.04.5.
Domain
Human medicine
Field of application
Eosinophiles Asthma, EGPA, CRSwNP, HES

Package details

Description (FR)
NUCALA sol inj 100 mg/ml stylo prérempli 3 pce
Description (DE)
NUCALA Inj Lös 100 mg/ml Fertigpen 3 Stk
Market launch
13/02/2020
Narcotic (BTM)
No

Other package sizes (1)

NUCALA sol inj 100 mg/ml stylo prérempli
1 STU
GTIN: 7680673500019
View